Knox Lane, a growth-oriented investment firm focused on the services and consumer sectors, has made a strategic investment in Spectrum Science, an independent marketing, communications and media firm focused on the pharmaceutical, biotech and life sciences industries.
Spectrum, owned by Jonathan Wilson, has served clients across the healthcare sector for nearly 30 years and employs over 300 individuals across the U.S. and U.K. The partnership looks to support the expansion of Spectrum’s strategic communications capabilities while helping the company build on its approach to clinical trial recruitment, expand consultative capabilities for medical affairs clients and drive technology throughout the organization.
Houlihan Lokey Inc. served as financial advisor and Alston & Bird LLP acted as legal counsel to Spectrum. Jefferies served as financial advisor and Kirkland & Ellis LLP acted as legal counsel to Knox Lane.